HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Clinical trials for HEMATOLOGIC AND LYMPHOCYTIC DISORDER explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC AND LYMPHOCYTIC DISORDER trials appear
Sign up with your email to follow new studies for HEMATOLOGIC AND LYMPHOCYTIC DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Living Drug' trial aims to calm immune attacks after transplants
Disease control TerminatedThis is a first-in-human study to test the safety and best dose of a new cell therapy for patients with chronic graft-versus-host disease (cGVHD). cGVHD is a serious condition where the immune cells from a donor transplant attack the patient's own body. The therapy involves givin…
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 04, 2026 04:51 UTC
-
Two-Drug combo aims to keep blood cancer at bay
Disease control OngoingThis study is testing whether a two-drug combination can help keep acute myeloid leukemia (AML) from returning in patients who have achieved remission. The trial involves 50 adults with AML who have responded to initial treatment but are not candidates for stem cell transplant. P…
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
New drug trial aims to stop Body's attack after Life-Saving transplants
Prevention OngoingThis study is testing if adding a new drug called itacitinib to standard treatment can prevent a serious complication called graft-versus-host disease (GVHD) in patients who receive a donor stem cell transplant for blood cancers. GVHD happens when the donor's immune cells attack …
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC
-
New hope to stop dangerous transplant complication
Prevention OngoingThis trial is testing if a drug called ustekinumab can prevent a serious complication called graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. About 116 patients will receive either the drug or a placebo alongside their standard transplant care. The…
Matched conditions: HEMATOLOGIC AND LYMPHOCYTIC DISORDER
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC